Successfully tested new cancer drugs

Scientists at the Cancer Research Institute in Sutton, UK have successfully clinical trials of a new drug called Olaparib in people at risk of breast cancer, ovarian cancer and cancer. prostate.

Breast cancer cells.Photo: Wordpress

Phase 1, scientists used Olaparib to treat 60 patients with BRCA1 and BRCA2 gene mutations or families with a history of cancer related to the BRCA gene. The follow-up results showed that none of the patients had serious diseases such as breast cancer, ovarian cancer, prostate cancer and other forms of cancer.

In the next stage, the scientists tested the drug on a smaller group of patients that also had two variants of the BRCA1 and BRCA2 genes. As a result, Olaparib drugs are absorbed and eliminated from the body very quickly, while reducing the size of breast, ovarian and prostate cancer tumors.

According to scientists, Olaparib drugs "lock" the PARP, a protein involved in DNA repair and when PARP is controlled, the cancer cells involved in the BRCA gene will does not exist. /.